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Background
Idiopathic basal ganglia calcifications (IBGC), also
known as Fahr’s disease, are neurological diseases char-
acterized by symmetric calcium deposits in basal ganglia
and other brain regions. Clinically, IBGC patients show
high phenotypic heterogeneity, both in the clinical mani-
festations and neuroradiological findings. Recently,
PDGFRB, PDGFB, XPR1 and SLC20A2 have been identi-
fied as causative genes for IBGC [1].
The aim of this study was to report on two Italian
patients with idiopathic basal ganglia calcifications asso-
ciated with novel mutations in the SLC20A2 gene who
both presented with episodic migraine.
Materials and methods
Two 48-year-old unrelated women presented to the
Headache Center, Department of Neuroscience “Rita
Levi Montalcini”, University of Torino, with a long-last-
ing history of headache. The reported symptoms fulfilled
ICHD-III beta version criteria for episodic migraine
without aura (code 1.1). Computed tomography scans
showed in both cases severe calcifications at the bilateral
globus pallidus, caudate nuclei, putamen, and dentate
nuclei. On the basis of neuroradiological findings,
SLC20A2 gene was sequenced.
Results
A novel missense mutation Gly63Asp (exon 1) and a fra-
meshift mutation p.Val507Glufs*2 (c.1520_1521delTG,
exon 8) in the isoform 1 of the SLC20A2 gene were identi-
fied. In silico analysis showed that the first substitution was
predicted to have a damaging role. For the frameshift
mutation, the genetic variant was found to change an ami-
noacid and insert a stop codon, likely leading to a degrada-
tion of the mutated messenger RNA.
Discussion and conclusions
The clinical manifestations in patients with IBGC range
widely from neurological and psychiatric symptoms to
asymptomatic status [2]. We suggest that migraine should
be considered when evaluating patients with IBGC and
first-degree relatives, in particular in young age, when
other neurological symptoms are absent. The identifica-
tion of new genetic variants further enlarge the spectrum
of mutations in SLC20A2, helping to better elucidate the
worldwide distribution and the different clinical features.
Written informed consent to publication was obtained
from the patient(s).
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